Spasticity management and progress in ambulatory cerebral palsy;Avancées dans le traitement de la spasticité et enfant IMOC

Archives de Pediatrie

Volumn 13, Issue 6, 2006, Pages 614-615

  Filipetti, P ^a   Caldas, C ^a   Delpierre, Y ^a  

^a centre de l'Arche I   (France)

Author keywords

Botulinum toxin; Cerebral palsy; Intrathecal baclofen; Selective dorsal rhizotomy; Spasticity

Indexed keywords

BACLOFEN; BOTULINUM TOXIN; BOTULINUM TOXIN A;

CEREBRAL PALSY; DORSAL RHIZOTOMY; GAIT DISORDER; HUMAN; INFANT DISEASE; LETTER; MUSCLE DISEASE; QUADRICEPS FEMORIS MUSCLE; SPASTICITY; TREATMENT INDICATION; AMBULATORY CARE; ARTICLE; BIOMECHANICS; CHILD; FOLLOW UP; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; INTRASPINAL DRUG ADMINISTRATION; LONG TERM CARE; MULTIMODALITY CANCER THERAPY; NEWBORN; ORTHOTICS; PRESCHOOL CHILD; RHIZOTOMY; TREATMENT OUTCOME;

AMBULATORY CARE; BACLOFEN; BIOMECHANICS; BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SPINAL; LONG-TERM CARE; MUSCLE SPASTICITY; ORTHOTIC DEVICES; RHIZOTOMY; TREATMENT OUTCOME;

EID: 33646903058     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2006.03.089     Document Type: Letter

References (2)

1. Gage J.R. The treatment of gait problems in cerebral palsy (2004), Mac Keith Press, Cambridge (424 p)
2. Graham H.K., Aoki K.R., Autti-Ramo I., et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 11 (2000) 67-79